Calyxt (CLXT) Receiving Somewhat Favorable News Coverage, Report Finds

Media headlines about Calyxt (NASDAQ:CLXT) have trended somewhat positive recently, Accern Sentiment reports. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Calyxt earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned media stories about the company an impact score of 45.6434268818651 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

How to Become a New Pot Stock Millionaire

Several equities analysts recently weighed in on the company. Zacks Investment Research cut Calyxt from a “hold” rating to a “sell” rating in a research report on Tuesday, January 2nd. Ladenburg Thalmann assumed coverage on Calyxt in a research report on Wednesday, December 20th. They set a “buy” rating and a $34.25 price objective for the company. ValuEngine raised Calyxt from a “sell” rating to a “hold” rating in a report on Wednesday, March 14th. Finally, Jefferies Group reaffirmed a “buy” rating and issued a $27.00 price target on shares of Calyxt in a report on Thursday, March 1st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the stock. Calyxt presently has an average rating of “Hold” and an average target price of $29.05.

Calyxt stock traded up $3.02 during trading hours on Tuesday, hitting $17.40. The stock had a trading volume of 234,548 shares, compared to its average volume of 63,784. The company has a quick ratio of 13.52, a current ratio of 13.52 and a debt-to-equity ratio of 0.18. The stock has a market cap of $433.56 and a price-to-earnings ratio of -15.54. Calyxt has a fifty-two week low of $9.26 and a fifty-two week high of $31.89.

Calyxt (NASDAQ:CLXT) last posted its quarterly earnings results on Tuesday, March 13th. The company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.03). The firm had revenue of $0.19 million during the quarter, compared to analyst estimates of $0.10 million. Calyxt had a negative net margin of 5,164.61% and a negative return on equity of 75.53%. analysts expect that Calyxt will post -1.31 earnings per share for the current fiscal year.

In other news, insider Daniel F. Voytas sold 4,666 shares of the stock in a transaction that occurred on Tuesday, March 20th. The stock was sold at an average price of $17.91, for a total value of $83,568.06. Following the completion of the transaction, the insider now directly owns 4,666 shares of the company’s stock, valued at approximately $83,568.06. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Daniel F. Voytas sold 4,083 shares of the stock in a transaction that occurred on Monday, April 9th. The stock was sold at an average price of $14.38, for a total value of $58,713.54. The disclosure for this sale can be found here. In the last ninety days, insiders sold 108,579 shares of company stock valued at $2,104,642.

COPYRIGHT VIOLATION NOTICE: “Calyxt (CLXT) Receiving Somewhat Favorable News Coverage, Report Finds” was originally published by Macon Daily and is owned by of Macon Daily. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://macondaily.com/2018/04/17/calyxt-clxt-receiving-somewhat-favorable-news-coverage-report-finds.html.

Calyxt Company Profile

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans.

Insider Buying and Selling by Quarter for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply